GSK Canada and Pan-Canadian Pharmaceutical Alliance sign LOI for Blenrep

GSK Canada and the Pan-Canadian Pharmaceutical Alliance signed a letter of intent (LOI) related to Blenrep for a type of multiple myeloma.